Massar Capital Management LP Takes Position in Teleflex Incorporated (NYSE:TFX)

Massar Capital Management LP acquired a new position in Teleflex Incorporated (NYSE:TFX) during the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm acquired 1,860 shares of the medical technology company’s stock, valued at approximately $331,000.

Several other hedge funds have also recently bought and sold shares of TFX. Vontobel Holding Ltd. raised its holdings in shares of Teleflex by 21.9% during the fourth quarter. Vontobel Holding Ltd. now owns 1,393 shares of the medical technology company’s stock valued at $248,000 after buying an additional 250 shares during the last quarter. JPMorgan Chase & Co. boosted its position in Teleflex by 14.3% during the 3rd quarter. JPMorgan Chase & Co. now owns 155,158 shares of the medical technology company’s stock worth $38,374,000 after acquiring an additional 19,466 shares during the period. Sumitomo Mitsui Trust Group Inc. grew its stake in shares of Teleflex by 5.2% in the fourth quarter. Sumitomo Mitsui Trust Group Inc. now owns 108,231 shares of the medical technology company’s stock worth $19,263,000 after purchasing an additional 5,322 shares in the last quarter. Lecap Asset Management Ltd. bought a new stake in shares of Teleflex during the fourth quarter valued at about $729,000. Finally, Mirae Asset Global Investments Co. Ltd. lifted its holdings in Teleflex by 35.1% in the fourth quarter. Mirae Asset Global Investments Co. Ltd. now owns 5,875 shares of the medical technology company’s stock worth $1,053,000 after purchasing an additional 1,527 shares during the period. 95.62% of the stock is currently owned by institutional investors.

Teleflex Stock Down 0.1 %

Shares of Teleflex stock opened at $129.33 on Tuesday. The company has a current ratio of 2.42, a quick ratio of 1.39 and a debt-to-equity ratio of 0.37. Teleflex Incorporated has a 1 year low of $124.66 and a 1 year high of $249.91. The stock has a 50-day moving average price of $142.90 and a 200 day moving average price of $176.30. The company has a market cap of $6.00 billion, a P/E ratio of 25.71, a P/E/G ratio of 1.73 and a beta of 1.19.

Teleflex (NYSE:TFX) last posted its quarterly earnings results on Thursday, February 27th. The medical technology company reported $3.89 EPS for the quarter, topping the consensus estimate of $3.86 by $0.03. The business had revenue of $795.40 million during the quarter, compared to analysts’ expectations of $813.24 million. Teleflex had a net margin of 7.85% and a return on equity of 14.19%. As a group, analysts expect that Teleflex Incorporated will post 13.98 EPS for the current fiscal year.

Teleflex Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Monday, March 17th. Investors of record on Friday, March 7th were issued a dividend of $0.34 per share. The ex-dividend date of this dividend was Friday, March 7th. This represents a $1.36 annualized dividend and a dividend yield of 1.05%. Teleflex’s dividend payout ratio is 95.77%.

Analyst Ratings Changes

TFX has been the subject of a number of research analyst reports. Needham & Company LLC reaffirmed a “hold” rating on shares of Teleflex in a research note on Wednesday, March 12th. Morgan Stanley dropped their price objective on Teleflex from $275.00 to $191.00 and set an “overweight” rating on the stock in a research note on Wednesday, March 5th. Citizens Jmp lowered Teleflex from an “outperform” rating to a “market perform” rating in a report on Thursday, February 27th. Royal Bank of Canada downgraded shares of Teleflex from an “outperform” rating to a “sector perform” rating and cut their price target for the company from $220.00 to $155.00 in a report on Friday, February 28th. Finally, Truist Financial dropped their target price on shares of Teleflex from $149.00 to $140.00 and set a “hold” rating on the stock in a report on Friday, April 11th. One analyst has rated the stock with a sell rating, nine have given a hold rating and two have issued a buy rating to the company’s stock. Based on data from MarketBeat.com, the company currently has an average rating of “Hold” and a consensus target price of $169.63.

About Teleflex

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.